Advanced Pancreatic Carcinoma
13 clinical trials · Condition
◉ Watch Advanced Pancreatic Carcinoma
| Record | Firm | Date |
|---|---|---|
| A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer (NCT05257122) | Fudan University | 2022-02-01 |
| CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer (NCT05143151) | Shenzhen University General Hospital | 2021-07-01 |
| Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study (NCT03033225) | Mayo Clinic | 2017-05-31 |
| Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets (NCT01454180) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2011-10-01 |
Track Advanced Pancreatic Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.